Chronic Thromboembolic Disease clinical trials at UCSF
1 research study open to eligible people
Chronic thromboembolic disease occurs when blood clots cause blockages in lung arteries. UCSF is conducting research to track the disease's development in patients. This registry aims to collect data on chronic thromboembolic pulmonary hypertension.
Chronic Thromboembolic Disease Registry
open to eligible people ages 18 years and up
The goal of this patient registry is to learn about the natural history in patients with chronic thromboembolic disease (CTD) and/or chronic thromboembolic pulmonary hypertension (CTEPH). The main question[s] it aims to answer are: - Long-term outcome after various types of treatment, including medication, balloon pulmonary angioplasty, and pulmonary endarterectomy - Effect of treatment on patient's quality of life and exercise tolerance Participants will be followed longitudinally to assess their health outcomes and quality of life via chart review and health quality surveys.
San Francisco, California
Our lead scientists for Chronic Thromboembolic Disease research studies include Miles Conrad, MD.
Last updated: